Les Laboratoires Servier SAS

Les Laboratoires Servier SAS

Les Laboratoires Servier SAS

Overview
Date Founded

1954

Headquarters

50, rue Carnot,Suresnes, Ile-de-France 92284

Type of Company

Private

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries

Company Description

Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France.

Executives & Employees

President

GM-Worldwide Production & Information Technology

Director of Research Center, Research & Development Directorate

Director, Servier Bioinnovation

Director, Servier Bioinnovation

Senior Executive Vice President-Human Resources

Chief Scientific & Executive Vice President-Research & Development

Secretary General

Media Relations Contact

Board of Directors

President at Les Laboratoires Servier SAS

Paths to Les Laboratoires Servier SAS
Potential Connections via
Relationship Science
You
Les Laboratoires Servier SAS
Recent Transactions
Details Hidden

Les Laboratoires Servier SAS purchases Symphogen A/S

Details Hidden

Les Laboratoires Servier SAS, Servier Laboratories Ltd. purchase Cti Biopharma Corp. /Pixuvri from CTI BioPharma Corp.

Details Hidden

Les Laboratoires Servier SAS purchases Shire Plc /Oncology Business from Shire Plc

Transaction Advisors
Investment Advisor

Advised onLes Laboratoires Servier SAS purchases Shire Plc /Oncology Business from Shire Plc

Investment Advisor

Advised onArts et Techniques du Progrès SAS, Les Laboratoires Servier SAS purchase Egis Pharmaceuticals Plc

Legal Advisor

Advised onArts et Techniques du Progrès SAS, Les Laboratoires Servier SAS purchase Egis Pharmaceuticals Plc

Legal Advisor

Advised onArts et Techniques du Progrès SAS, Les Laboratoires Servier SAS purchase Egis Pharmaceuticals Plc

Legal Advisor

Advised onArts et Techniques du Progrès SAS, Les Laboratoires Servier SAS purchase Egis Pharmaceuticals Plc

Legal Advisor

Advised onArts et Techniques du Progrès SAS, Les Laboratoires Servier SAS purchase Egis Pharmaceuticals Plc

Clients

Jeil Pharma Holdings, Inc. engages in the management of its subsidiaries. Its services include consulting, rental, and others. The company was founded on March 7, 1959 and is headquartered in Seoul, South Korea.

Jeil Pharmaceutical Co., Ltd. engages in the development of pharmaceuticals. It operates through the Pharmaceutical and Other business divisions. The Pharmaceutical division offers drugs for antibiotic, oncology, cardiovascular, gastrointestinal, neuropsychiatry, urology, endocrinology, respiratory, antiviral, musculoskeletal, and others. The company was founded in March 1959 and is headquartered in Seoul, South Korea.

KT&G Corp. engages in the manufacture and sale of tobacco products. It operates through the Tabacoo and Real Estate Business Divisions. The Tobacco Division manufactures and distributes raw materials needed in production of tobacco. The Real Estates division offers rentals, sales, and housing development. The company was founded on April 1, 1987 and is headquartered in Daejeon, South Korea.

Suppliers
CTI BioPharma Corp. Biotechnology | Seattle, WA

CTI BioPharma Corp. is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

Vernalis Plc Wholesale: Consumer Non-Durables/Sundries | Winnersh, United Kingdom

Vernalis Plc is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market; Moxatag, a once-a-day formulation of the antibiotic and amoxicillin; and frovatriptan, used for the acute treatment of migraine. Vernalis also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh in 1986 and is headquartered in Winnersh, the United Kingdom.

Hybrigenics SA Biotechnology | Paris, Fra

Hybrigenics SA operates as a biopharmaceutical company, which engages in the research and development of targets and therapies against proliferative diseases. It develops inecalcitol for the treatment of prostate cancer, chronic lymphocytic leukemia, and chronic myeloid leukemia. The company was founded on December 29, 1997 and is headquartered in Paris, France.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Les Laboratoires Servier SAS. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Les Laboratoires Servier SAS's profile does not indicate a business or promotional relationship of any kind between RelSci and Les Laboratoires Servier SAS.